Taylor Zhang

Taylor Zhang is a Director in Product and Analytical Department in Cell Therapy Development and Operations at Bristol Myers Squibb, in Seattle, Washington. Prior to Bristol Myers Squibb, he was a Principal Scientist and group leader in the Protein Analytical Chemistry Department at Genentech. He received his PhD in Analytical Chemistry from Iowa State University.

Taylor Zhang

Bristol Myers Squibb

Articles by Taylor Zhang

  • Characterization of DNA Impurities in Cell Therapies

    Wednesday, February 24, 2021
    T cells play important roles in adaptive immunity by serving as sentinels against foreign pathogens. T cells that have been engineered to recognize cancer-specific antigens present a promising treatment option for a number of... read more
  • <<
  • >>